Year Ahead: State Drug Pricing

Despite Being An Off Year, Lots Of State Action On Drug Prices Expected

By John Wilkerson / January 16, 2020 at 11:01 AM
Although it’s an off year for state legislatures, states are expected to make progress on legislation and initiatives to lower drug prices, and state attorneys general are showing more interest in protecting residents from high drug prices, according to National Academy for State Health Policy Executive Director Trish Riley. The policies to watch include drug imports, bulk purchasing, insulin spending caps and drug price review boards. Drug Imports The Trump administration proposed a rule last month to let states...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.